The Vital Role of Diversity in Clinical Trials

Improving diversity in your clinical research has the potential to shorten product approval timelines, prevent label changes and market withdrawals, avoid penalties and give you an advantage over competitors.

Download our white paper The Vital Role of Diversity in Clinical Trials for a three-pronged approach to help address clinical trial enrollment and participation gaps by:

1. Establishing enrollment goals and geolocate patient subpopulations
2. Using patient-centric strategies to engage diverse and underrepresented patient populations
3. Incorporating modernized study design elements to connect with patients where they live                 

UBC’s multidisciplinary team of evidence development, epidemiology, clinical strategy and patient services experts provide key insights and considerations for building a comprehensive diversity plan, including how to:

• Leverage real-world data to identify patient and provider populations
• Break through diversity participation barriers
• Incorporate modernized study design elements designed to increase engagement

Make diversity planning a standard component of your clinical trial planning process before the FDA’s Draft Guidance on Diversity Action Plans (DAPs) is finalized.

 Get started by completing the form to access our white paper The Vital Role of Diversity in Clinical Trials.